← Open Payments lookup

TEYLOR MARTINEZ: Open Payments

NPI 1396361630 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$784 in 34 payments from 16 companies in 2025. Trend: 2023 $428 · 2024 $795 · 2025 $784

Food & beverage: $784
CompanyPaymentsAmount
Daiichi Sankyo Inc.10$213
Janssen Biotech, Inc.5$134
Merck Sharp & Dohme LLC3$68
SOBI, INC2$55
Pharmacosmos Therapeutics Inc.2$51
Genentech USA, Inc.2$41
E.R. Squibb & Sons, L.L.C.1$32
Takeda Pharmaceuticals U.S.A., Inc.1$27
BeOne Medicines USA, Inc.1$26
Incyte Corporation1$23

Products named: Enhertu, DATROWAY, TECVAYLI, MONOFERRIC, KEYTRUDA, RYBREVANT, Gamifant, OPDIVO.

Industry payments across DC — which companies pay providers there.